Literature DB >> 9506334

Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing.

T Fukuda1, T Akagi, M Ishibashi, O Inoue, T Sugimura, H Kato.   

Abstract

The sensitivities of dipyridamole stress thallium 201 single photon emission computed tomography (SPECT) and treadmill exercise testing in the detection of myocardial ischemia were compared. Thirty-eight patients with Kawasaki disease and 11 age-matched controls participated in the study. Fifteen of the 38 patients with Kawasaki disease had marked coronary artery stenosis (> 75%) in at least one vessel. SPECT scans were obtained immediately after dipyridamole infusion and 4 hours later. The sensitivity of SPECT for detection of coronary stenosis was 80% (12/15), whereas that of treadmill exercise testing was only 33% (5/15) (p < 0.001). Although the sensitivity of SPECT significantly exceeded that of treadmill exercise testing among patients with coronary stenosis in only one vessel (p < 0.05), such benefits were not found for patients with stenosis in two or three vessels. These findings suggest that dipyridamole stress SPECT has a higher degree of sensitivity in the detection of myocardial ischemia than does treadmill exercise testing, especially for patients with single-vessel disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506334     DOI: 10.1016/s0002-8703(98)70325-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy.

Authors:  Tsuyoshi Fukuda; Masatoshi Ishibashi; Tatsuo Yokoyama; Masaki Otaki; Tohru Shinohara; Yoshihide Nakamura; Toshiharu Miyake; Takashi Kudoh; Hidetaka Oku
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Procedure guidelines for radionuclide myocardial perfusion imaging.

Authors:  C Anagnostopoulos; M Harbinson; A Kelion; K Kundley; C Y Loong; A Notghi; E Reyes; W Tindale; S R Underwood
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

3.  Follow-up assessment of the collateral circulation in patients with Kawasaki disease who underwent dipyridamole stress technetium-99m tetrofosmin scintigraphy.

Authors:  T Fukuda; M Ishibashi; T Shinohara; T Miyake; T Kudoh; T Saga
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

Review 4.  Long-term cardiac sequelae of Kawasaki disease.

Authors:  D R Fulton; J W Newburger
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

5.  Percutaneous transluminal coronary angioplasty for coronary arterial stenosis in a 10-year-old boy with Kawasaki disease and a brief review.

Authors:  Meng-Luen Lee; Chien-Hsun Hsia
Journal:  Pediatr Cardiol       Date:  2007-09-11       Impact factor: 1.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.